New Levels Breached In Drug Discovery By Biology-Driven AI

With the assistance of biology-driven AI, drug development is about to enter an age that will make it even more efficient, effective, as well as affordable.

Better Outcomes On Crohns Disease Treatment - UK Research

Studies indicate that when it comes to Crohns disease, top-down treatment with an immunomodulator improves the patient outcomes better than step-up therapy.

New Treatment For Endometrial Cancer Gets Clearance From NHS

The NHS has given its approval to a novel immunotherapy that may give women suffering due to advanced endometrial cancer a substantial amount of extra time.

Enhancing Power of Medicare Drug Price, Proposed By Biden

The White House wants to give Medicare the ability to bargain for 50 medications per year, which is a big increase from the current 20 that are included in IRA.

Bachem in conversation with ChromaCon founders

Get an insight into a conversation about lessons in innovation, what it is like to partner with Bachem, and – of course – the potentials of continuous chromatography.

Pharma and Biotech’s Green Revolution

At its core the production of life-saving medicines for patients all over the world is meaningful and sustainable. Yet, there is still a considerable environmental impact in terms of waste disposal.

By Automating Traditional Methods, CROs Stand To Benefit

The continued contract resource organizations use by big pharma necessitates that the former get access to pharmacovigilance automation for better outcomes.